- Tytuł:
- 72P Camrelizumab plus apatinib after chemoradiotherapy in unresectable stage III non-small cell lung cancer: A multi-center, single-arm, phase II study
- Autorzy:
- Źródło:
- In Immuno-Oncology and Technology December 2023 20 Supplement
Czasopismo naukowe